OrganOx
Manufacturing · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Business Park 3500 John Smith Oxford Dr,...Phone Number
+44 1865504024Website
www.organox.comRevenue
$50.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
3
1
1
1
1
About OrganOx
OrganOx is a medical technology company focused on advancing organ preservation and transplantation through innovative organ perfusion systems. Originating as a spin-out from a leading academic institution, the company is dedicated to transforming the field of organ care by developing technologies that improve the viability and usability of donor organs. Its mission is centered on enabling better clinical outcomes and increasing the number of successful transplants by redefining how organs are preserved outside the human body.Explore more
OrganOx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OrganOx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once OrganOx has new funding data
Product Launch: Get notified when OrganOx launches new products
Check out if OrganOx is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if OrganOx had a recent Job posting/layoffs
Check if OrganOx has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at OrganOx
Earning: See what the market has to say on OrganOx recently announced quarterly report
OrganOx, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to OrganOx
Compare insights from companies similar to OrganOx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
OrganOx
$50.1M
51-200
Private
$174.6M
2008
Kd
Katerina de MetzVice President, Clinical Affairs & Training (North America)
Company Profile Activity
Activity Insights
OrganOx is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
OrganOx is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about OrganOx.
OrganOx financials insights
Gather financial insights about OrganOx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Private Equity
$32.6M
2025
Other Financing Round
$142M
OrganOx Tech Stack
A closer look at the technologies used by OrganOx
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Open Position
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
Hiring Plans
Hiring Plans
OrganOx News & Media
Terumo completes acquisition of University of Oxford spinout OrganOx for a record $1.5bn
OrganOx, a pioneering Oxford University spinout transforming kidney and liver transplantation, has been fully acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo, Japan, for US$1.5 billion, marking the largest exit in Oxford University’s spinout portfolio to date and the first in excess of £1bn. The agreement for the acquisition wasTerumo completes $1.5B acquisition of OrganOx - MassDevice
OrganOx today announced the completion of its acquisition by Terumo in a deal valued at approximately $1.5 billion.OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation
$1.5 billion OrganOx acquisition by Terumo strengthens global leadership in organ technology and accelerates progress toward making every organ countOrganOx metra® Receives FDA Approval for Operation During Air Transport, Expanding Access to Life-Saving Liver Perfusion Technology
Partnership with Strata Critical Medical (NASDAQ:SRTA) enables 24/7, device-to-donor support across the U.S. Partnership with Strata Critical Medical (NASDAQ:SRTA) enables 24/7, device-to-donor support across the U.S.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OrganOx
Sign Up For FreeTo access detailed company insights
OrganOx is a medical technology company focused on advancing organ preservation and transplantation through innovative organ perfusion systems. Originating as a spin-out from a leading academic institution, the company is dedicated to transforming the field of organ care by developing technologies that improve the viability and usability of donor o... Read More
